The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate. 2010

J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, New York 10029, USA.

Age-related osteoporosis is accompanied by an increase in marrow adiposity and a reduction in serum insulin-like growth factor-1 (IGF-1) and the binding proteins that stabilize IGF-1. To determine the relationship between these proteins and bone marrow adiposity, we evaluated the adipogenic potential of marrow-derived mesenchymal stromal cells (MSCs) from mice with decreased serum IGF-1 due to knockdown of IGF-1 production by the liver or knock-out of the binding proteins. We employed 10-16-week-old, liver-specific IGF-1-deficient, IGFBP-3 knock-out (BP3KO) and acid-labile subunit knock-out (ALSKO) mice. We found that expression of the late adipocyte differentiation marker peroxisome proliferator-activated receptor gamma was increased in marrow isolated from ALSKO mice. When induced with adipogenic media, MSC cultures from ALSKO mice revealed a significantly greater number of differentiated adipocytes compared with controls. MSCs from ALSKO mice also exhibited decreased alkaline-phosphatase positive colony size in cultures that were stimulated with osteoblast differentiation media. These osteoblast-like cells from ALSKO mice failed to induce osteoclastogenesis of control cells in co-culture assays, indicating that impairment of IGF-1 complex formation with ALS in bone marrow alters cell fate, leading to increased adipogenesis.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
August 1988, The Journal of clinical endocrinology and metabolism,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
January 2000, Endocrinology,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
October 1992, Biochemical and biophysical research communications,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
June 1992, Molecular endocrinology (Baltimore, Md.),
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
December 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
March 2004, Journal of biochemistry and molecular biology,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
December 1997, The Journal of clinical endocrinology and metabolism,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
March 2002, Journal of biochemistry and molecular biology,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
February 1994, Endocrinology,
J Christopher Fritton, and Yuki Kawashima, and Wilson Mejia, and Hayden-Williams Courtland, and Sebastien Elis, and Hui Sun, and Yinjgie Wu, and Clifford J Rosen, and David Clemmons, and Shoshana Yakar
October 1996, Biochemical and biophysical research communications,
Copied contents to your clipboard!